Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Brittany Craiglow

Dermatology Fairfield, CT Medical Doctor

NPI 1053554667 CMS profile 479077

140 Sherman St Fl 3, Fairfield, CT 06824

Open in the dashboard

General payments

$1,940,047

1,343 records reported · program years 2019–2025

Research payments

$10,900

Paid to them · 11 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Brittany Craiglow of Fairfield, CT is reported in the CMS Open Payments database as having received $1,940,047 across 1,343 general payments and $10,900 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Dermatology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

12 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $307,057 158
2025 Research $3,200 1
2024 General $399,291 273
2024 Research $940 1
2023 General $350,992 230
2023 Research $2,540 4
2022 General $335,706 255
2022 Research $1,880 2
2021 General $187,639 139
2020 General $117,844 90
2020 Research $2,340 3
2019 General $241,519 198

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Brittany Craiglow
  • Dermatology median
  • Middle half of Dermatology
  • National median

In program year 2025, general payments to Brittany Craiglow were reported at $307,057. Among 10,363 Dermatology profiles paid that year, the median was $788 and the middle half received between $207 and $1,974.

Show as a table
Year Brittany Craiglow Dermatology median Middle half National median
2019 $241,519 $454 $129–$1,240 $163
2020 $117,844 $235 $81–$756 $114
2021 $187,639 $377 $108–$1,108 $132
2022 $335,706 $514 $143–$1,391 $149
2023 $350,992 $607 $159–$1,674 $160
2024 $399,291 $751 $204–$1,903 $164
2025 $307,057 $788 $207–$1,974 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Pfizer Inc. $530,171 241 payments
  2. Genzyme Corporation $408,466 265 payments
  3. Regeneron Healthcare Solutions, Inc. $368,707 295 payments
  4. Lilly USA, LLC $294,638 267 payments
  5. AbbVie, Inc. $114,440 95 payments
  6. Eli Lilly and Company $91,932 44 payments
  7. Incyte Corporation $59,965 63 payments
  8. Dermavant Sciences, Inc. $26,373 20 payments
  9. Sun Pharmaceutical Industries Inc. $17,932 8 payments
  10. Arcutis Biotherapeutics, Inc. $9,083 5 payments
  11. Other $18,341 40 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,377,515 421 payments
  2. Consulting Fee $345,096 108 payments
  3. Travel and Lodging $143,773 278 payments
  4. Honoraria $50,725 12 payments
  5. Food and Beverage $22,934 523 payments
  6. Education $5 1 payment
Products named General payments · program years 2019–2025
  1. DUPIXENT Immunology $469,344 312 payments
  2. DUPIXENT Inflammation And Immunology $326,974 274 payments
  3. LITFULO $239,232 108 payments
  4. OLUMIANT $207,799 102 payments
  5. CIBINQO $112,709 70 payments
  6. RINVOQ $102,275 87 payments
  7. DUPIXENT Immunology $81,673 60 payments
  8. OPZELURA $52,774 56 payments
  9. EBGLYSS $52,147 57 payments
  10. DUPIXENT Immunology And Inflammation $41,732 21 payments
  11. Other $109,380 187 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Pfizer Inc. $10,900 11 payments

Records

1,354 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Dermatology in Connecticut

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record